메뉴 건너뛰기




Volumn 344, Issue 20, 2001, Pages 1527-1535

Oral contraceptives and the risk of venous thrombosis

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; GESTAGEN; LOW DOSE ORAL CONTRACEPTIVE;

EID: 0035902193     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200105173442007     Document Type: Review
Times cited : (511)

References (98)
  • 10
    • 0031610077 scopus 로고    scopus 로고
    • Cardiovascular disease and steroid hormone contraception: Report of a WHO scientific group
    • (1998) WHO Tech Rep Ser , vol.877 , pp. 1-89
  • 11
    • 0032574524 scopus 로고    scopus 로고
    • Using epidemiological data to guide clinical practice: Review of studies on cardiovascular disease and use of combined oral contraceptives
    • (1998) BMJ , vol.316 , pp. 984-987
    • Hannaford, P.C.1    Owen-Smith, V.2
  • 14
    • 0029564931 scopus 로고
    • Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study
    • (1995) Lancet , vol.346 , pp. 1575-1582
  • 18
    • 0014431877 scopus 로고
    • Investigation of relation between use of oral contraceptives and thromboembolic disease
    • (1968) BMJ , vol.2 , pp. 199-205
    • Vessey, M.P.1    Doll, R.2
  • 22
    • 13344260005 scopus 로고
    • Effect of different progestogens in low dose oestrogen oral contraceptives on venous thromboembolic disease
    • (1995) Lancet , vol.346 , pp. 1582-1588
  • 28
    • 0031856577 scopus 로고    scopus 로고
    • Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism
    • (1998) J Intern Med , vol.244 , pp. 27-32
    • Bennet, L.1    Odeberg, H.2
  • 34
    • 0033017609 scopus 로고    scopus 로고
    • The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives
    • (1999) Int J Fertil Womens Med , vol.44 , pp. 19-30
    • Burnhill, M.S.1
  • 39
    • 0034679260 scopus 로고    scopus 로고
    • Risk of fatal pulmonary embolism with oral contraceptives
    • (2000) Lancet , vol.355 , pp. 2088
    • Poulter, N.R.1
  • 40
    • 0034702492 scopus 로고    scopus 로고
    • Third generation oral contraceptives
    • (2000) BMJ , vol.321 , pp. 190-191
    • Skegg, D.C.G.1
  • 44
    • 0029615479 scopus 로고
    • Third-generation oral contraceptives: How risky?
    • (1995) Lancet , vol.346 , pp. 1570
    • Weiss, N.1
  • 45
    • 0030581824 scopus 로고    scopus 로고
    • Third generation oral contraception and venous thromboembolism
    • (1996) BMJ , vol.312 , pp. 68-69
    • McPherson, K.1
  • 46
    • 0032034139 scopus 로고    scopus 로고
    • Newer oral contraceptives and the risk of venous thromboembolism
    • (1998) Contraception , vol.57 , pp. 169-181
    • Walker, A.M.1
  • 47
    • 0033604120 scopus 로고    scopus 로고
    • The third generation oral contraceptive controversy: The evidence shows they are less safe than second generation pills
    • (1999) BMJ , vol.319 , pp. 795-796
    • O'Brien, P.A.1
  • 48
    • 0003193159 scopus 로고    scopus 로고
    • Combined oral contraceptives containing desogestrel or gestodene and the risk of venous thromboembolism
    • (1999) Curr Probl Pharmacovigilance , vol.25 , pp. 12
  • 56
    • 0029033740 scopus 로고
    • Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)
    • (1995) Blood , vol.85 , pp. 2756-2761
    • Koster, T.1    Rosendaal, F.R.2    Briët, E.3
  • 70
    • 0028290275 scopus 로고
    • Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa
    • (1994) J Biol Chem , vol.269 , pp. 18735-18738
    • Shen, L.1    Dahlbäck, B.2
  • 76
    • 0030934739 scopus 로고    scopus 로고
    • Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- and third-generation oral contraceptives
    • (1997) Br J Haematol , vol.97 , pp. 233-238
    • Rosing, J.1    Tans, G.2    Nicolaes, G.A.F.3
  • 81
  • 83
    • 0033947981 scopus 로고    scopus 로고
    • Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: A randomized cross-over study of two low-dose oral contraceptives
    • (2000) Thromb Haemost , vol.84 , pp. 9-14
    • Meijers, J.C.M.1    Middeldorp, S.2    Tekelenburg, W.3
  • 89
    • 4243280555 scopus 로고    scopus 로고
    • Wellington, New Zealand: New Zealand Department of Health, December. (See http://www.medsafe.govt.nz/Profs/PUarticles.htm.) (See NAPS document no. 05591 for 3 pages, c/o Microfiche Publications, 248 Hempstead Tpke., West Hempstead, NY 11552.)
    • (1998) Deaths with third generation oral contraceptives
  • 93
    • 0031870121 scopus 로고    scopus 로고
    • Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study
    • (1998) Contraception , vol.57 , pp. 315-324
  • 94
    • 0030065643 scopus 로고    scopus 로고
    • Thrombosis, phlebitis and varicose veins
    • (1996) BMJ , vol.312 , pp. 198-199
    • Campbell, B.1
  • 97
    • 0030585170 scopus 로고    scopus 로고
    • Gesundheitsökonomische evaluation des screenings auf APC-resistenz (mutation leiden) bei neuanwenderinnen von ovulationshemmern
    • (1996) Med'Klin , vol.91 , pp. 317-319
    • Szucs, T.1    Osterkorn, D.2    Schramm, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.